Simply Wall St.
Arcutis Biotherapeutics (ARQT) Valuation Check After New Pediatric ZORYVE Phase 3 Extension Data
📊
AI Sentiment
Positive
7/10
Arcutis Biotherapeutics Inc. News
Latest updates and market news for ARQT
1 news
Mar 23 - Mar 29, 2026
Page 1
Share this news page